Lv3
210 积分 2022-12-15 加入
Exposure–response relationship of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis
1个月前
已完结
Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting
5个月前
已完结
Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling
7个月前
已完结
Hypoxic and acidic tumor microenvironment-driven AVL9 promotes chemoresistance of pancreatic ductal adenocarcinoma via the AVL9-IκBα-SKP1 complex
7个月前
已完结
Pharmacokinetic Modeling of VV116 for Treatment of COVID-19
8个月前
已完结
Discovery and Development of VV116: A Novel Oral Nucleoside Anti‐SARS‐CoV‐2 Drug
8个月前
已完结
Renal dysfunction during osimertinib treatment in patients with non–small cell lung cancer positive for EGFR mutations
9个月前
已完结
皖公网安备34019202002308
